480 related articles for article (PubMed ID: 35116510)
41. Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma.
Weng C; Wang L; Liu G; Guan M; Lu L
Front Oncol; 2021; 11():763027. PubMed ID: 34868980
[TBL] [Abstract][Full Text] [Related]
42. Prognostic Implications of Pyroptosis-Related Gene Signatures in Lung Squamous Cell Carcinoma.
Li T; Liu H; Dong C; Lyu J
Front Pharmacol; 2022; 13():806995. PubMed ID: 35153782
[No Abstract] [Full Text] [Related]
43. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
Front Immunol; 2021; 12():653836. PubMed ID: 33897701
[No Abstract] [Full Text] [Related]
44. Mining the potential prognostic value of synaptosomal-associated protein 25 (SNAP25) in colon cancer based on stromal-immune score.
Zou J; Duan D; Yu C; Pan J; Xia J; Yang Z; Cai S
PeerJ; 2020; 8():e10142. PubMed ID: 33150073
[TBL] [Abstract][Full Text] [Related]
45. A Novel Pyroptosis-Related Gene Signature for Early-Stage Lung Squamous Cell Carcinoma.
Li X; He J
Int J Gen Med; 2021; 14():6439-6453. PubMed ID: 34675612
[TBL] [Abstract][Full Text] [Related]
46. Exploring Prognostic Immune Microenvironment-Related Genes in Head and Neck Squamous Cell Carcinoma from the TCGA Database.
Li S; Zeng Y; He L; Xie X
J Cancer; 2024; 15(3):632-644. PubMed ID: 38213736
[No Abstract] [Full Text] [Related]
47. Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma.
He Q; Xue S; Wa Q; He M; Feng S; Chen Z; Chen W; Luo X
Medicine (Baltimore); 2021 Apr; 100(17):e25715. PubMed ID: 33907159
[TBL] [Abstract][Full Text] [Related]
48. A new prognostic model for glioblastoma multiforme based on coagulation-related genes.
Zhou M; Deng Y; Fu Y; Liang R; Liu Y; Liao Q
Transl Cancer Res; 2023 Oct; 12(10):2898-2910. PubMed ID: 37969372
[TBL] [Abstract][Full Text] [Related]
49. A ferroptosis-related gene signature for overall survival prediction and immune infiltration in lung squamous cell carcinoma.
Miao TW; Yang DQ; Chen FY; Zhu Q; Chen X
Biosci Rep; 2022 Aug; 42(8):. PubMed ID: 35866375
[TBL] [Abstract][Full Text] [Related]
50. Development of a Clinical Prognostic Model for Metabolism-Related Genes in Squamous Lung Cancer and Correlation Analysis of Immune Microenvironment.
Zhuang Z; Gao C
Biomed Res Int; 2022; 2022():6962056. PubMed ID: 36110123
[TBL] [Abstract][Full Text] [Related]
51. Comprehensive Analysis of Immune Implication and Prognostic Value of
Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
Front Oncol; 2021; 11():798425. PubMed ID: 35047409
[TBL] [Abstract][Full Text] [Related]
52. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
53. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
54. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
Shi T; Gao G
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
[TBL] [Abstract][Full Text] [Related]
55. Hippo Pathway Core Genes Based Prognostic Signature and Immune Infiltration Patterns in Lung Squamous Cell Carcinoma.
Gu C; Chen J; Dang X; Chen C; Huang Z; Shen W; Shi X; Dai C; Chen C
Front Oncol; 2021; 11():680918. PubMed ID: 33996611
[TBL] [Abstract][Full Text] [Related]
56. Expression of gasdermin D in clear cell renal cell carcinoma and its effect on its biological function.
Zhang J; Wang Y; Ma J; Aimudula A
Front Oncol; 2023; 13():1163714. PubMed ID: 37483501
[TBL] [Abstract][Full Text] [Related]
57. Systematic analysis identifies three-lncRNA signature as a potentially prognostic biomarker for lung squamous cell carcinoma using bioinformatics strategy.
Hu J; Xu L; Shou T; Chen Q
Transl Lung Cancer Res; 2019 Oct; 8(5):614-635. PubMed ID: 31737498
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
[TBL] [Abstract][Full Text] [Related]
59. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
Ke D; Guo Q; Fan TY; Xiao X
Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657
[No Abstract] [Full Text] [Related]
60. Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma.
Liu Y; Jia W; Li J; Zhu H; Yu J
Front Oncol; 2020; 10():587343. PubMed ID: 33117720
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
